Dusal, Pablita T.

HRN: 23-95-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
CEFAZOLIN 1GM (VIAL)
10/25/2023
11/01/2023
IV
1g
Q8H
Fracture, STI
Waiting Final Action 
11/05/2023
CEFAZOLIN 1GM (VIAL)
11/06/2023
11/12/2023
IVT
500mg
Q6
Subtrochanteric Fracture Right Femur Sec To Mva, For Or
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: